HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Hennon Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

5/2023Analyzing the impact of minimally invasive surgical approaches on post-operative outcomes of pneumonectomy and sleeve lobectomy patients.
11/2018A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer.
1/2018Role of Segmentectomy in Treatment of Early-Stage Non-Small Cell Lung Cancer.
1/2018Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.
11/2017Transcervical Extended Mediastinal Lymphadenectomy: Experience From a North American Cancer Center.
1/2017Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Hennon Research Topics

Disease

10Neoplasms (Cancer)
06/2023 - 03/2013
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023 - 01/2017
4Adenocarcinoma
06/2023 - 01/2018
3Neoplasm Metastasis (Metastasis)
06/2023 - 01/2016
2Margins of Excision
01/2021 - 11/2018
2Esophageal Neoplasms (Esophageal Cancer)
12/2019 - 01/2019
2Lung Neoplasms (Lung Cancer)
01/2018 - 03/2013
2Carcinoma (Carcinomatosis)
01/2017 - 03/2013
1Brain Neoplasms (Brain Tumor)
06/2023
1Acute Pain
01/2023
1Pathologic Constriction (Stenosis)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2019
1Pneumonia (Pneumonitis)
01/2018
1Hemorrhage
01/2017
1Intraoperative Complications
11/2016
1Neoplasm Micrometastasis
03/2013

Drug/Important Bio-Agent (IBA)

1Opioid Analgesics (Opioids)IBA
01/2023
12',3'- didehydro- 2',3'- dideoxy- 5- chlorocytidineIBA
07/2021
1thiamine triphosphorate (TTP)IBA
07/2021
1ElementsIBA
11/2017
1Iridium-192IBA
11/2016
1Vascular Endothelial Growth Factor DIBA
03/2013
1Keratin-7 (Cytokeratin 7)IBA
03/2013
1Carcinoembryonic AntigenIBA
03/2013
1human FLT4 proteinIBA
03/2013
1Messenger RNA (mRNA)IBA
03/2013
1Cell Adhesion MoleculesIBA
03/2013
1Proteins (Proteins, Gene)FDA Link
03/2013
1Vascular Endothelial Growth FactorsIBA
03/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2013
1Vascular Endothelial Growth Factor CIBA
03/2013

Therapy/Procedure

5Therapeutics
08/2022 - 01/2016
4Radiotherapy
07/2021 - 01/2017
3Drug Therapy (Chemotherapy)
06/2023 - 11/2018
3Esophagectomy
01/2020 - 01/2018
3Neoadjuvant Therapy
01/2019 - 11/2017
2Pneumonectomy (Lung Volume Reduction)
05/2023 - 01/2017
2Length of Stay
01/2021 - 01/2018
2Lymph Node Excision (Lymph Node Dissection)
11/2018 - 11/2017
2Segmental Mastectomy (Lumpectomy)
01/2018 - 01/2018
1Adjuvant Chemotherapy
06/2023
1Thoracotomy
01/2021
1Immunotherapy
01/2017
1Operative Time
11/2016
1Brachytherapy
11/2016